A Nature Cell Biology study shows that vitamin B2 metabolism helps cancer cells evade ferroptosis by stabilizing ferroptosis ...

ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is ...

Health and Pharma is a pioneering news and communications platform focused on health science, biotechnology, and pharmaceutical developments.

Oregon Therapeutics & Lantern Pharma launch a strategic AI collaboration to optimize XCE853, a novel cancer drug candidate. Demonstrating efficacy in solid and hematological cancers, XCE853 is poised ...

The Phase III SUNMO trial could mark a breakthrough for transplant-ineligible patients with relapsed or refractory large B-cell lymphoma. In this ONCOLife interview, we spoke with Dr. Jason Westin, ...

Oncolytic viruses are a very promising class of therapeutic agents, with a broad range of types. They not only infect and kill cancer cells, but also modulate the tumor micro-environment to enhance ...

Despite two decades of clinical experience with Everolimus in transplant medicine, cancer patients continue to face preventable toxicities and fatal adverse events. While transplant patients benefit ...

Novartis announced that its drug Ribociclib (Kisqali®) combined with endocrine therapy (ET) demonstrates a sustained 28.5% reduction in distant recurrence for high-risk HR+/HER2- early breast cancer ...

ConcertAI and Caris Life Sciences have formed a strategic partnership with AbbVie to accelerate oncology research and clinical trials. Utilizing AI and ML, they will leverage extensive clinical and ...

Carine has 20+ years of experience in big pharma’s. Here, she speaks as a patient, with early Breast Cancer. After an initial response, her prognosis got compromised by disease progression in her ...

ONCOLife proudly presents an exclusive interview with Dr. Joana Reis, Global Medical Affairs Lead, Breast Imaging, Radiology at Bayer. In this session, we explore how AI-driven advancements are ...